Avalo Therapeutics, Inc. · NASDAQ:AVTX
Ikarian Capital, LLC's stake in Avalo Therapeutics, Inc. fell to 3.80% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Ikarian Capital, LLC's stake in Avalo Therapeutics, Inc. fell to 3.80%, 711,967 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 3.80%
- Shares
- 711,967
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 3.80% | 711,967 |
| Neil Shahrestani | 3.80% | 711,967 |
Source
Related
- Avalo Therapeutics, Inc.
- Ikarian Capital, LLC
- Avalo Therapeutics, Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · May 15, 2025
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026